OUR STORE IS CLOSED ON ANZAC DAY: THURSDAY 25 APRIL

Close Notification

Your cart does not contain any items

Icelandic Cure

Omnidawn Fabulist Fiction Prize

J.D. Moyer

$11.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
OMNIDAWN PRESS
03 April 2018
"In the year 2021, Jane Tokugawa leads a U.S. delegation from the Centers for Disease Control to investigate a new retroviral gene therapy approved in Iceland, a shining nation churning out Olympic medalists, chess masters, and brilliant artists. As Tokugawa learns more about the Hratthníf protocol from head scientist/founder Ásdís Lúthersdóttir, she begins to question the motives of some of her delegation's members. Hratthníf

(""fast knife"") is curing diseases and mental illness, changing lives for the better. But who controls it? What are the limits? As the true mission of her delegation becomes clear, Tokugawa makes a decision that will affect millions of lives."

By:  
Imprint:   OMNIDAWN PRESS
Country of Publication:   United States
Dimensions:   Height: 178mm,  Width: 152mm,  Spine: 6mm
Weight:   88g
ISBN:   9781632430519
ISBN 10:   1632430517
Series:   The Omnidawn Fabulist Fiction Prize
Pages:   72
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

J.D. Moyer lives in Oakland, California, with his wife, daughter, and mystery-breed dog. He writes science fiction, produces electronic music in two groups (Jondi & Spesh and Momu), runs a record label (Looq Records), and blogs at jdmoyer.com. His previous stories have appeared in Strange Horizons and Cosmic Roots And Eldritch Shores. He is currently working on his first novel, The Sky Woman.

Reviews for Icelandic Cure (Omnidawn Fabulist Fiction Prize)

Moyer's novelette, winner of the 2016 Omnidawn Fabulist Fiction Prize, is a curious blend of ethical thought exercise and medical jargon couched in introspection. Jane Tokugawa is a representative of the U.S. Center for Disease Control, part of a delegation sent to Iceland to learn about a new gene-altering technology that promises to revolutionize health care and potentially eradicate physical and mental illnesses. -- Publishers Weekly (1/1/2018 12:00:00 AM)


See Also